PDF) Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil
Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil | Cost Effectiveness and Resource Allocation | Full Text
Optimální léčba chronické HCV infekce s použitím přímo působících virostatik | Remedia
Interferon-based therapy for chronic hepatitis C: current and future perspectives | Nature Reviews Gastroenterology & Hepatology
PDF) Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil
Peginterferon Lambda - an overview | ScienceDirect Topics
Pegylated Interferon alpha-2b, (PegIFN), Virafin – Drug Approvals International
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness - ScienceDirect
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE)
Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil | Cost Effectiveness and Resource Allocation | Full Text
eigr-10k_20201231.htm
PASylation improves pharmacokinetic of liposomes and attenuates anti-PEG IgM production: An alternative to PEGylation - ScienceDirect
Peginterferon Alfa 2a Injection at Rs 500/unit | Antiviral Medicine in Nagpur | ID: 22305080591
Peginterferon-α-2a (40kD) Plus Ribavirin | Drugs
Peginterferon Alfa 2a Injection at Rs 500/unit | Antiviral Medicine in Nagpur | ID: 22305080591
Appendix 2 Protocol template guide
Peginterferon alfa-2a
Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain | Gastroenterología y Hepatología
PDF) Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil
EP0809996A2 - Interferon conjugates - Google Patents
PDF) Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil
Frontiers | Role of Type I and II Interferons in Colorectal Cancer and Melanoma
